THBS1 and neoplasm: We and others have shown that selectively blocking TSP1-CD47 interaction leads to protection of T cells from anti-tumor radiation therapy through enhanced metabolic fitness [59], greater anti-tumor activity [43,60], and greater radiation efficacy with low/no side effects in syngeneic mouse tumor models [61].